Live Quote · OTCLIPOHealthcare· Biotechnology

Lipella Pharmaceuticals Inc.

$0.13 0.00%(+$0.00)
TickerSpark Score
64/100
Mixed
75
Valuation
20
Profitability
90
Growth
84
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LIPO research report →

52-Week Range12% of range
Low
$0.02
Current
$0.13
High
$0.94
Company Overviewwww.lipella.com

About the company

Lipella Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm specializing in the creation of novel therapies. The company achieves this by repurposing and optimizing the active ingredients found in established generic drugs, tailoring these reformulations for diverse medical applications.

CEO
Jonathan Kaufman
IPO
2022
Employees
5
HQ
Pittsburgh, PA, US

Price Chart

-84.15% · this period
$0.85$0.44$0.02Jul 02Dec 31Jul 02
Valuation
Market Cap
$600.71K
P/E
-0.05
P/S
3.46
P/B
0.40
EV/EBITDA
0.19
Div Yield
0.00%
Profitability
Gross Margin
-1954.73%
Op Margin
-3115.15%
Net Margin
-3068.97%
ROE
-208.44%
ROIC
-308.84%
Growth & Income
Revenue
$536.36K · 19.29%
Net Income
$-5,016,264 · -8.60%
EPS
$-4.79 · 22.24%
Op Income
$-5,080,542
FCF YoY
-24.84%
Performance & Tape
52W High
$0.94
52W Low
$0.02
50D MA
$0.08
200D MA
$0.24
Beta
1.50
Avg Volume
35.70K

Get TickerSpark's AI analysis on LIPO

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 3, 25Kaufman Jonathan Hother536,959
Apr 3, 25Kaufman Jonathan Hother4,060
Mar 13, 25Kaufman Jonathan Hother10,326
Mar 13, 25Kaufman Jonathan Hother4,060
Mar 10, 25Kaufman Jonathan Hother84,700
Mar 10, 25Kaufman Jonathan Hother28,924
Feb 28, 25Kaufman Jonathan Hother441,933
Feb 28, 25Kaufman Jonathan Hother125,833
Jan 15, 25Kaufman Jonathan Hother11,795
Jan 15, 25Kaufman Jonathan Hother303,041
Coverage · LIPO

Our LIPO coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on LIPO yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate LIPO report →
Internal Compare

Similar companies

Peers in the same neighborhood.